XML 26 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities:      
Net income (loss) $ (1,959) $ (615) $ (2,499)
Adjustments to reconcile net income (loss) to net cash provided by operations:      
Impairment of goodwill 1,280 700 2,045
Impairment of long-lived assets and assets held for sale 1,275 378 402
Depreciation and amortization 1,059 1,153 1,308
Net change in operating assets and liabilities (435) (72) 1,355
Deferred income taxes — net and uncertain tax positions (634) (317) (1,064)
Stock-based compensation 123 121 124
Net loss (gain) from sale of business and long-lived assets (22) (41) 10
Other items 560 61 (91)
Net cash provided by (used in) operating activities 1,247 1,368 1,590
Investing activities:      
Beneficial interest collected in exchange for securitized trade receivables 1,291 1,477 1,140
Purchases of property, plant and equipment and intangible assets (498) (526) (548)
Proceeds from sale of business and long lived assets 43 68 68
Purchases of investments and other assets (71) (46) (1)
Proceeds from sale of investments 40 0 4
Acquisitions of businesses, net of cash acquired (15) 0 (7)
Other investing activities 2 (5) 0
Net cash provided by (used in) investing activities 792 968 656
Financing activities:      
Repayment of senior notes and loans and other long term liabilities (1,641) (4,152) (1,369)
Proceeds from senior notes, net of issuance costs 0 2,451 0
Proceeds from short term debt 0 700 0
Repayment of short term debt 0 (700) 0
Purchase of shares from non-controlling interests (64) 0 0
Dividends paid to non-controlling interests (78) 0 0
Other financing activities (8) (212) (118)
Net cash provided by (used in) financing activities (1,791) (1,913) (1,487)
Translation adjustment on cash and cash equivalents (174) (30) (123)
Net change in cash, cash equivalents and restricted cash 74 393 636
Balance of cash, cash equivalents and restricted cash at beginning of year 3,227 2,834 2,198
Balance of cash, cash equivalents and restricted cash at end of year 3,300 3,227 2,834
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:      
Cash and cash equivalents 3,300 3,226 2,801
Restricted cash included in other current assets 0 1 33
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 3,300 3,227 2,834
Non-cash financing and investing activities:      
Beneficial interest obtained in exchange for securitized trade receivables 1,286 1,446 1,189
Dividend declared to non-controlling interests 0 67 0
Cash paid during the year for:      
Interest 1,004 1,078 948
Income taxes, net of refunds 471 298 543
Net change in operating assets and liabilities:      
Other current assets (1,104) (1,525) (828)
Trade payables, accrued expenses, employee-related obligations and other liabilities 258 1,588 2,012
Trade receivables net of sales reserves and allowances 245 12 334
Inventories 166 (147) (163)
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information $ (435) $ (72) $ 1,355